Affimed NV Ownership
| AFMD Stock | USD 2.62 0.02 0.76% |
Shares in Circulation | First Issued 2014-03-31 | Previous Quarter 15 M | Current Value 16 M | Avarage Shares Outstanding 8 M | Quarterly Volatility 5 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Affimed |
Affimed Stock Ownership Analysis
About 37.0% of the company shares are held by institutions such as insurance companies. The book value of Affimed NV was presently reported as 3.85. The company recorded a loss per share of 4.76. Affimed NV had not issued any dividends in recent years. The entity had 1:10 split on the 11th of March 2024. Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Affimed N.V. was founded in 2000 and is headquartered in Heidelberg, Germany. Affimed NV operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 197 people. For more info on Affimed NV please contact Adi Hoess at 49 621 560030 or go to https://www.affimed.com.Besides selling stocks to institutional investors, Affimed NV also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Affimed NV's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Affimed NV's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Affimed NV Quarterly Liabilities And Stockholders Equity |
|
About 6.0% of Affimed NV are currently held by insiders. Unlike Affimed NV's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Affimed NV's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Affimed NV's insider trades
Affimed Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Affimed NV is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Affimed NV backward and forwards among themselves. Affimed NV's institutional investor refers to the entity that pools money to purchase Affimed NV's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | State Street Corp | 2024-06-30 | 55.1 K | Walleye Trading Advisors, Llc | 2024-06-30 | 24.1 K | Commonwealth Equity Services Inc | 2024-06-30 | 21.6 K | Abrdn Plc | 2024-09-30 | 20.9 K | Dimensional Fund Advisors, Inc. | 2024-09-30 | 18.1 K | Fmr Inc | 2024-09-30 | 17.7 K | Blackrock Inc | 2024-06-30 | 16.3 K | Clayton Financial Group Llc | 2024-06-30 | 15 K | Cubist Systematic Strategies, Llc | 2024-09-30 | 14 K | 683 Capital Management Llc | 2024-09-30 | 650 K | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 559.6 K |
Affimed NV Outstanding Bonds
Affimed NV issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Affimed NV uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Affimed bonds can be classified according to their maturity, which is the date when Affimed NV has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Affimed NV Corporate Filings
6K | 14th of November 2024 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges. | ViewVerify |
| 8th of November 2024 Other Reports | ViewVerify | |
| 4th of November 2024 Other Reports | ViewVerify | |
13A | 24th of October 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Affimed NV is a strong investment it is important to analyze Affimed NV's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Affimed NV's future performance. For an informed investment choice regarding Affimed Stock, refer to the following important reports:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Affimed NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. For information on how to trade Affimed Stock refer to our How to Trade Affimed Stock guide.You can also try the Stocks Directory module to find actively traded stocks across global markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Affimed NV. If investors know Affimed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Affimed NV listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.76) | Revenue Per Share 0.493 | Quarterly Revenue Growth (0.90) | Return On Assets (0.49) | Return On Equity (1.24) |
The market value of Affimed NV is measured differently than its book value, which is the value of Affimed that is recorded on the company's balance sheet. Investors also form their own opinion of Affimed NV's value that differs from its market value or its book value, called intrinsic value, which is Affimed NV's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Affimed NV's market value can be influenced by many factors that don't directly affect Affimed NV's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Affimed NV's value and its price as these two are different measures arrived at by different means. Investors typically determine if Affimed NV is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Affimed NV's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.